KZR
Kezar Life Sciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.29
+0.00%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-69.3%
Return on equity
-66.5%
Return on assets
-63.1%
Return on invested capital
0.00x
Asset turnover
-$42.0M
Cash from operations
$8.96
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026